Electrochemiluminescence Immunoassay for Antibodies to Epstein-Barr Virus (EBV) Nuclear Antigen (IgG)

Why This Test Matters: Understanding Your EBV Exposure

EBV is a virus that can affect many parts of the body, including the immune system, throat, and even the brain. While many people recover fully from an EBV infection, some may experience long-term effects or develop conditions like chronic fatigue syndrome or certain cancers. Measuring EBV IgG antibodies helps doctors track your immune response and diagnose past infections.

How the Test Works

The test uses a blood sample to detect specific antibodies (IgG) your immune system produces in response to EBV. These antibodies are a sign that your body has encountered the virus before. The test is performed using a sensitive immunoassay method that detects these antibodies with high accuracy.

What the Results May Indicate

Positive results suggest you have developed antibodies against EBV, indicating past infection and long-term immunity. Negative results mean you either haven’t been exposed to EBV or your immune system hasn’t produced detectable antibodies yet. It’s important to note that this test alone cannot confirm an active EBV infection; other tests may be needed for that purpose.

Common Uses for This Test

Doctors may order this test to diagnose or monitor EBV-related conditions, such as evaluating immune function, assessing risk for certain cancers (like Burkitt lymphoma or nasopharyngeal carcinoma), or checking for past exposure in research or clinical studies.